| Title |
Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors
|
|---|---|
| Published in |
Cochrane database of systematic reviews, February 2015
|
| DOI | 10.1002/14651858.cd007259.pub2 |
| Pubmed ID | |
| Authors |
Nerida L Klupp, Dennis Chang, Fiona Hawke, Hosen Kiat, Huijuan Cao, Suzanne J Grant, Alan Bensoussan |
| Abstract |
Ganoderma lucidum (also known as lingzhi or reishi) is a mushroom that has been consumed for its broad medicinal properties in Asia for over 2000 years. G lucidum is becoming increasingly popular in western countries as a complementary medicine for cardiovascular health. |
X Demographics
The data shown below were collected from the profiles of 20 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Peru | 3 | 15% |
| Saudi Arabia | 2 | 10% |
| Colombia | 2 | 10% |
| United States | 2 | 10% |
| Spain | 1 | 5% |
| Canada | 1 | 5% |
| Unknown | 9 | 45% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 20 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 350 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 350 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 55 | 16% |
| Researcher | 43 | 12% |
| Student > Bachelor | 40 | 11% |
| Student > Ph. D. Student | 24 | 7% |
| Other | 20 | 6% |
| Other | 56 | 16% |
| Unknown | 112 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 100 | 29% |
| Nursing and Health Professions | 27 | 8% |
| Agricultural and Biological Sciences | 22 | 6% |
| Biochemistry, Genetics and Molecular Biology | 15 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 15 | 4% |
| Other | 50 | 14% |
| Unknown | 121 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 74. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 August 2023.
All research outputs
#577,710
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#1,037
of 11,499 outputs
Outputs of similar age
#6,866
of 269,228 outputs
Outputs of similar age from Cochrane database of systematic reviews
#22
of 251 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 269,228 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 251 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.